Plasmid-Determined Colistin Resistance in the North African Countries: A Systematic Review.

Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
Abdelaziz Touati, Assia Mairi

Abstract

We have conducted a systematic review to update available information on plasmid-mediated colistin resistance (mobilized colistin resistance [mcr]) genes in North African countries. We have searched the articles of PubMed, Scopus, and Web of Science databases reporting plasmid-mediated colistin resistance bacteria isolated in North African countries. After searching and selection, 30 studies that included 208 mcr-positive isolates were included. Different mcr-positive strains frequencies were recorded and ranged from 2% in clinical isolates to 12.3% in environmental samples. Escherichia coli was the predominant species recorded and these microorganisms showed high resistance to ciprofloxacin and cotrimoxazole. IncHI2 plasmids are probably the key vectors responsible for the dissemination of mcr genes in these countries. This review highlighted that the mcr-positive isolates are circulating in different ecological niches with different frequencies. Therefore, actions should be implemented to prevent the dissemination of the mcr genes within and outside of these countries, such as microbiological and molecular surveillance programs and restriction use of colistin in farming.

References

Jul 1, 1985·Applied and Environmental Microbiology·M J GauthierJ P Breittmayer
Nov 22, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Sohini SarkarJeff Kuper
Mar 26, 2008·Critical Care Clinics·Argyris Michalopoulos, Matthew E Falagas
May 20, 2009·BMC Bioinformatics·Alexandre P FranciscoJoão A Carriço
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Oct 3, 2009·Current Opinion in Infectious Diseases·Roger L Nation, Jian Li
May 10, 2012·BMC Bioinformatics·Alexandre P FranciscoJoäo A Carriço
May 27, 2015·European Journal of Clinical Pharmacology·Atefeh Ordooei JavanZahra Sahraei
Dec 30, 2015·The Lancet Infectious Diseases·Abiola Olumuyiwa OlaitanJean-Marc Rolain
Mar 5, 2016·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Raoudha GramiMarisa Haenni
Mar 10, 2016·Antimicrobial Agents and Chemotherapy·Shimaa S ElnahriryTadashi Shimamoto
Apr 27, 2016·International Journal of Antimicrobial Agents·Hazim O KhalifaTadashi Shimamoto
May 29, 2016·International Journal of Antimicrobial Agents·Mohamed RhoumaAnn Letellier
Jul 16, 2016·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Basil Britto XavierSurbhi Malhotra-Kumar
Aug 31, 2016·Antimicrobial Agents and Chemotherapy·Meryem BerrazegJean-Marc Rolain
Oct 16, 2016·International Journal of Antimicrobial Agents·Betitera YanatJosé-Manuel Rodríguez-Martínez
Mar 7, 2017·PloS One·Nicolle Lima BarbieriCatherine M Logue
May 28, 2017·Clinical Pharmacokinetics·Nicolas GrégoireWilliam Couet
Jul 18, 2017·Journal of Global Antimicrobial Resistance·Wejdène MansourJean-Yves Madec
Aug 12, 2017·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Alessandra CarattoliChiara Francesca Magistrali
Aug 12, 2017·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Jalila MohsinAgnes Sonnevend
Aug 15, 2017·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Soumia BrahmiJean-Philippe Lavigne
Sep 8, 2017·Antimicrobial Resistance and Infection Control·Katrin ZurfluhRoger Stephan
Nov 2, 2017·The Journal of Antimicrobial Chemotherapy·Manal AbuOunMuna F Anjum
Dec 5, 2017·International Journal of Antimicrobial Agents·Ruichao LiSheng Chen
Dec 12, 2017·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Taous BachiriAbdelaziz Touati
Jan 23, 2018·Journal of Global Antimicrobial Resistance·Iman DandachiJean-Marc Rolain
Mar 12, 2018·Trends in Microbiology·Jian SunYoujun Feng
Apr 19, 2018·Animal Health Research Reviews·Jian SunJun Lin
May 31, 2018·Antimicrobial Agents and Chemotherapy·Erik SnesrudPatrick McGann
Jun 13, 2018·The Science of the Total Environment·Rezak DraliFawzia Mouffok
Jun 19, 2018·The Journal of Antimicrobial Chemotherapy·Yong-Qiang YangHong-Ning Wang
Jul 5, 2018·Emerging Microbes & Infections·Xiaoming WangYang Wang
Sep 24, 2018·Plasmid·Monika Dolejska, Costas C Papagiannitsis

❮ Previous
Next ❯

Software Mentioned

MLST
Scopus
goeBURST
PHYLOVIZ

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.